跳至內容

吲哚瑞酯

維基百科,自由的百科全書
吲哚瑞酯
識別資訊
  • methyl 3-amino-2-(5-methoxy-1H-indol-3-yl)propanoate
CAS號73758-06-2  checkY
PubChem CID
ChemSpider
UNII
CompTox Dashboard英語CompTox Chemicals Dashboard (EPA)
化學資訊
化學式C13H16N2O3
摩爾質量248.277 g/mol
3D模型(JSmol英語JSmol
  • COC(=O)C(CN)c1cnc(ccc2OC)c1c2

吲哚瑞酯(英語:IndorenateTR-3369)是一種色胺衍生物,常作為5-HT1A英語5-HT1A receptor5-HT1B英語5-HT1B receptor5-HT2C英語5-HT2C receptor血清素受體激動劑。它具有抗焦慮降壓降食慾英語anorectic的作用,主要是通過激動5-HT1A受體來完成,但5-HT1B和5-HT2C也有可能起一定作用,另外一些非血清素受體也可能是它的靶標。[1][2][3][4][5][6][7][8][9]

另見

[編輯]

參考文獻

[編輯]
  1. ^ Antonaccio MJ, Kerwin L. On the effects and mechanism of action of the antihypertensive agent TR 3369 (5-methoxytryptamine beta-methylcarboxylate) in spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology. 1981, 3 (6): 1306–11. PMID 6173531. 
  2. ^ Schoeffter P, Hoyer D. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. British Journal of Pharmacology. November 1988, 95 (3): 975–85. PMC 1854240可免費查閱. PMID 3207999. 
  3. ^ Fernández-Guasti A, Escalante A, Hong E, Agmo A. Behavioural actions of the serotonergic anxiolytic indorenate. Pharmacology, Biochemistry, and Behavior. September 1990, 37 (1): 83–8. PMID 1979877. doi:10.1016/0091-3057(90)90045-J. 
  4. ^ López Cabrera M, Velázquez Martínez DN, Prado R, García G, Ortiz R. Effects of the intracerebroventricular administration of indorenate and fenfluramine on spontaneous behavior and food intake in rats. Proceedings of the Western Pharmacology Society. 1991, 34: 465–8. PMID 1788330. 
  5. ^ Velázquez-Martínez DN, López Cabrera M, Sánchez H, Ramírez JI, Hong E. Discriminative stimulus properties of indorenate, a serotonin agonist. Journal of Psychiatry & Neuroscience : JPN. March 1999, 24 (2): 122–30. PMC 1188992可免費查閱. PMID 10212554. 
  6. ^ Sánchez H, Velázquez-Martínez DN. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats. Journal of Psychopharmacology (Oxford, England). March 2001, 15 (1): 29–36. PMID 11277605. 
  7. ^ Miranda F, Orozco G, Velázquez-Martínez DN. Full substitution of the discriminative cue of a 5-HT(1A/1B/2C) agonist with the combined administration of a 5-HT(1B/2C) and a 5-HT(1A) agonist. Behavioural Pharmacology. July 2002, 13 (4): 303–11. PMID 12218511. 
  8. ^ Miranda F, Hong E, Sánchez H, Velázquez-Martínez DN. Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors. Pharmacology, Biochemistry, and Behavior. January 2003, 74 (2): 371–80. PMID 12479957. doi:10.1016/S0091-3057(02)01010-9. 
  9. ^ López-Meraz ML, Neri-Bazán L, Rocha L. Indorenate modifies a1-adrenergic and benzodiazepine receptor binding in the rat brain: an autoradiography study. The Journal of Pharmacy and Pharmacology. September 2006, 58 (9): 1243–8. PMID 16945183. doi:10.1211/jpp.58.9.0011.